Paul Friedemann

Professional Experience


2004 – 2009: Consultant and Senior Physician, Cecilie Vogt Clinic, Charité Universitätsmedizin Berlin

Since 2008: Head of research group “Clinical Neuroimmunology”, NeuroCure Clinical Research Center, Charité University Medicine Berlin

Since 2010: Head, research group, Clinical and Experimental Neuroimmunology, Experimental and Clinical Research Center, Charité Campus Buch

2011 ‐ 2016: Professor (W2), Neurology, NeuroCure Clinical Research Center, Charité

Since 2016:  Professor (W2), tenure professorship for Clinical and Experimental

Neuroimmunology, Charitè


Research fields

  • Neuromyelitis optica (Devic’s Syndrome)

  • Neurodegeneration  and  Neuroprotection  in  Multiple  Sclerosis  (MS)  and  Experimental Autoimmune Encephalomyelitis (EAE)

  • Neurological Complications  of  Chronic  Inflammatory  Bowel  Diseases  Diagnostic  Tools  in Neuro‐immunology (Imaging (OCT, MRI, Ultrasound), Laboratory, and CSF Biomarkers)

  • Association  of  structural  damage  and  dysfunction  of  the  visual  system  in  autoimmune disorders of the Central Nervous System

Other Scientific Activities, Honors, Awards


Since 2016: Medical Consultant for EU‐ Announcements for Research Programmes on Rare Diseases (E‐RARE)

Since 2015: Associate Editor “Neurology: Neuroimmunology and Neuroinflammation”

Since 2014: Medical Consultant for Science Council (BfarM)

Since 2013: Board member of the Competence Network Multiple Sclerosis (KKNMS)

Since 201:  Member of the Guthy Jackson Foundation Clinical Consortium


Since 2011: Academic Editor, PLoS ONE

Since 2009: Member, Editorial Board, EPMA Journal

Since 2009: National representative, European Association for Predictive, Preventive and Personalised Medicine (EPMA)

Since 2008: MS‐Subkommittee der European Neurological Society (ENS)

Since 2008: Co‐initiator, NEMOS‐Initiative, coordinator of the German Neuromyelitis optical study group (www.nemos‐

Institutional Support

Scientific Sponsors